Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

SeraCare Life Sciences’ launches new product to ensure accuracy of NGS assays
08-14-2015
SHARING OPTIONS:

SeraCare Life Sciences
 
SeraCare Life Sciences has launched its first product, the Seraseq Solid Tumor Mutation Mix-I (AF20), a biosynthetic reference material designed to evaluate the performance of next-generation sequencing (NGS)-based tumor profiling assays. This product contains a mixture of mutations in key oncogenes and tumor suppressor genes and is intended as a quality material for translational and disease research testing. In addition, it permits laboratories to monitor library preparation, sequencing and variant allele detection under a given set of bioinformatics pipeline or parameters. It is currently for research use only.
 
SeraCare Life Sciences

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.